The combination of two blood pressure medications (candesartan and hydrochlorothiazide) and a low-dose cholesterol-lowering drug (rosuvastatin) proved to be highly effective in reducing the risk of first-time strokes by 44% in patients with intermediate risk for heart disease. This finding was reported on January 25, 2018.